background
one
controversi
sourc
infect
hepat
c
viru
hcv
involv
share
contamin
implement
straw
spoon
use
nasal
inhal
cocain
powder
drug
essenti
precondit
mode
transmiss
presenc
hcv
nasal
secret
intranas
drug
user
method
blood
nasal
secret
sampl
collect
five
plasmaposit
chronic
intranas
drug
user
test
hcv
rna
use
rtpcr
result
hcv
detect
five
blood
sampl
nasal
secret
subject
highest
serum
viral
load
studi
first
demonstr
presenc
hcv
nasal
secret
find
implic
potenti
transmiss
hcv
contact
contamin
nasal
secret
hepat
c
viru
hcv
major
caus
liverrel
morbid
mortal
worldwid
estim
global
preval
million
chronic
infect
hcvinduc
liver
diseas
common
indic
liver
transplant
emerg
lead
caus
death
among
hospit
hivinfect
patient
treat
haart
era
transmiss
hcv
known
occur
contact
contamin
blood
notabl
context
inject
drug
use
transfus
blood
product
prior
chronic
hemodialysi
occup
exposur
blood
nosocomi
perinat
exposur
addit
sever
studi
report
low
level
suspect
sexual
household
transmiss
hcv
although
much
known
rout
hcv
transmiss
nearli
infect
individu
report
identifi
sourc
exposur
unexplain
case
particularli
high
among
drugus
histori
inject
risk
identifi
risk
factor
one
hypothesi
might
account
high
number
unexplain
hcv
infect
among
noninject
drugus
propos
research
us
nation
institut
health
nih
identifi
intranas
cocain
use
signific
risk
factor
hcv
among
volunt
blood
donor
reason
hcv
might
transmit
contamin
implement
straw
spoon
commonli
use
nasal
inhal
powder
drug
includ
heroin
cocain
methamphetamin
chronic
nasal
inhal
substanc
includ
adulter
contain
caus
tissu
deterior
bleed
nasal
membran
implement
insert
erod
nasal
caviti
may
come
contact
hcvinfect
mucu
blood
may
transmit
uninfect
individu
share
implement
debat
regard
potenti
mode
transmiss
intensifi
nation
heart
lung
blood
institut
nhlbi
retroviru
epidemiolog
donor
studi
red
unabl
confirm
intranas
drug
inhal
independ
risk
factor
hcv
conflict
report
prompt
american
associ
blood
bank
aabb
add
shortli
thereaft
remov
intranas
cocain
use
list
criteria
use
screen
potenti
blood
donor
subsequ
review
literatur
found
seriou
methodolog
limit
nih
nhlbire
studi
although
hcv
detect
saliva
semen
nonserolog
fluid
plasmaposit
patient
virolog
studi
undertaken
determin
whether
hcv
present
nasal
secret
intranas
drug
user
necessari
precondit
internas
viral
transmiss
report
preliminari
find
detect
hcv
rna
nasal
secret
plasmaposit
chronic
drug
sniffer
five
patient
recruit
studi
boriken
neighborhood
health
center
east
harlem
new
york
citi
subject
select
consecut
clinic
patient
previous
test
hcv
seroposit
report
histori
intranas
drug
use
first
four
subject
hcv
antibodi
reactiv
seroposit
quantit
pcr
fifth
subject
test
seroposit
hcv
antibodi
hcv
pcr
neg
copi
ml
subject
male
year
age
seroposit
tabl
present
patient
serolog
indic
hepat
c
well
hepat
b
alt
level
liver
biopsi
result
rna
precipit
ml
isopropyl
alcohol
min
follow
centrifug
g
min
wash
ethanol
rna
pellet
resuspend
rnasefre
water
detect
hcv
rna
perform
rtpcr
first
strand
cdna
synthes
first
strand
cdna
synthesi
kit
invitrogen
use
genespecif
downstream
primer
target
hcv
core
region
minor
modif
upstream
primer
hcv
cdna
amplifi
pcr
cycl
denatur
min
anneal
min
elong
min
subsequ
pcr
product
resolv
agaros
gel
electrophoresi
hybrid
plabel
intern
probe
expos
kodak
film
previou
studi
demonstr
presenc
hcv
wide
varieti
nonserolog
fluid
instanc
hcv
detect
saliva
sampl
plasmaposit
individu
reason
hcv
might
present
nasal
secret
similar
preval
would
therefor
detect
among
rel
small
sampl
virem
patient
five
consecut
plasmaposit
clinic
patient
select
studi
contribut
blood
nasal
secret
sampl
hcv
rtpcr
analysi
rtpcr
result
confirm
presenc
hcv
blood
five
subject
highest
serum
concentr
viral
rna
detect
subject
lowest
subject
see
fig
find
consist
patient
record
viral
load
noteworthi
assay
detect
hcv
rna
serum
subject
previous
level
detect
commerci
avail
assay
indic
lowlevel
viremia
verifi
high
sensit
analysi
hcv
rna
detect
serum
nasal
secret
five
intranas
drug
user
significantli
hcv
particl
also
detect
nasal
secret
subject
fig
subject
africanamerican
male
also
exhibit
highest
hcv
serum
viral
load
iuml
hcv
detect
nasal
secret
four
studi
subject
find
repres
first
demonstr
presenc
hcv
rna
nasal
secret
great
care
taken
avoid
sampl
contamin
phase
studi
blood
sampl
known
serolog
collect
five
subject
test
hcv
rna
confirm
valid
laboratori
procedur
trizol
assay
use
nasal
secret
sampl
studi
shown
effect
rna
isol
varieti
nonserolog
sampl
knowledg
first
studi
demonstr
presenc
hcv
nasal
secret
intranas
drugus
find
confirm
internas
viral
transmiss
lend
virolog
support
previou
indic
intranas
drug
use
pose
risk
confirm
import
precondit
rout
infect
addit
detect
hcv
nasal
secret
advanc
debat
regard
potenti
iatrogen
nosocomi
transmiss
hcv
context
ent
practic
research
involv
larger
sampl
need
replic
result
provid
accur
estim
hcv
preval
nasal
secret
plasmaposit
patient
determin
whether
intranas
hcv
deriv
blood
nasal
caviti
directli
nasal
secret
futur
research
also
address
whether
presenc
hcv
nasal
caviti
affect
progress
upper
respiratori
infect
influenza
rhinoviru
adenoviru
coronaviru
sever
acut
respiratori
viru
jm
princip
investig
conceiv
design
coordin
studi
prepar
report
ms
perform
viral
rna
isol
rtpcr
analysi
interpret
prepar
graphic
wrote
virolog
section
report
contribut
sever
revis
manuscript
dm
recruit
enrol
studi
subject
among
clinic
patient
administ
screen
inform
consent
collect
blood
nasal
secret
sampl
help
manuscript
revis
mc
contribut
design
coordin
studi
assist
revis
author
review
report
approv
final
version
